Key statistics
On Friday, Gritstone bio Inc (2JQ:FRA) closed at 0.57, 43.87% above the 52 week low of 0.3962 set on Aug 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.5285 |
---|---|
High | 0.57 |
Low | 0.5285 |
Bid | 0.546 |
Offer | 0.5675 |
Previous close | 0.4982 |
Average volume | 2.31k |
---|---|
Shares outstanding | 118.11m |
Free float | 115.85m |
P/E (TTM) | -- |
Market cap | 74.14m USD |
EPS (TTM) | -1.35 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 13:18 BST.
More ▼
Announcements
- Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
- Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
- Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine
- Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million
More ▼